Bionano Genomics, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2017 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Bionano Genomics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2017 to Q2 2024.
  • Bionano Genomics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$16.2M, a 58.3% increase year-over-year.
  • Bionano Genomics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$204M, a 39.3% decline year-over-year.
  • Bionano Genomics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$232M, a 75.3% decline from 2022.
  • Bionano Genomics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$133M, a 83.1% decline from 2021.
  • Bionano Genomics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$72.4M, a 76.2% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$204M -$16.2M +$22.7M +58.3% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 -$227M -$31.4M +$5.7M +15.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-08-07
Q4 2023 -$232M -$43.9M -$5.21M -13.5% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-05
Q3 2023 -$227M -$113M -$80.8M -254% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-08
Q2 2023 -$147M -$38.9M -$6.75M -21% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 -$140M -$37.1M -$7.17M -23.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-08-07
Q4 2022 -$133M -$38.7M -$15.7M -68.5% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-05
Q3 2022 -$117M -$31.8M -$11.1M -53.3% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 -$106M -$32.2M -$13.4M -71.2% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-08
Q1 2022 -$92.4M -$30M -$20M -201% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-08
Q4 2021 -$72.4M -$22.9M -$11.2M -95.6% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-09
Q3 2021 -$61.2M -$20.8M -$9.96M -92.3% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 -$51.3M -$18.8M -$10.7M -133% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-03
Q1 2021 -$40.5M -$9.95M +$563K +5.36% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-03
Q4 2020 -$41.1M -$11.7M -$3.83M -48.5% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-01
Q3 2020 -$37.3M -$10.8M -$4.39M -68.7% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 -$32.9M -$8.07M -$409K -5.34% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-04
Q1 2020 -$32.5M -$10.5M -$2.66M -33.9% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-04
Q4 2019 -$29.8M -$7.9M -$1.49M -23.2% Oct 1, 2019 Dec 31, 2019 10-Q 2020-08-13
Q3 2019 -$28.3M -$6.4M -$1.47M -29.9% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-13
Q2 2019 -$26.9M -$7.67M -$4.35M -131% Apr 1, 2019 Jun 30, 2019 10-Q 2020-11-13
Q1 2019 -$22.5M -$7.85M -$4M -104% Jan 1, 2019 Mar 31, 2019 10-Q 2020-11-13
Q4 2018 -$18.5M -$6.41M -$12.3M -208% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-10
Q3 2018 -$6.17M -$4.93M -$10M -197% Jul 1, 2018 Sep 30, 2018 10-K 2020-03-10
Q2 2018 $3.85M -$3.31M -$9.99M -150% Apr 1, 2018 Jun 30, 2018 10-K 2020-03-10
Q1 2018 $13.8M -$3.85M -$9.53M -168% Jan 1, 2018 Mar 31, 2018 10-K 2020-03-10
Q4 2017 $23.4M $5.92M Oct 1, 2017 Dec 31, 2017 10-K 2019-03-14
Q3 2017 $5.09M Jul 1, 2017 Sep 30, 2017 10-K 2019-03-14
Q2 2017 $6.67M Apr 1, 2017 Jun 30, 2017 10-K 2019-03-14
Q1 2017 $5.69M Jan 1, 2017 Mar 31, 2017 10-K 2019-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.